27-hydroxycholesterol has been researched along with Coronary Heart Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Böhm, M; Laufs, U; Lütjohann, D; Weingärtner, O | 1 |
Allison, M; Aragaki, AK; Eaton, C; Hoogeveen, RC; Hsia, J; Jackson, R; Johnson, KC; Kuller, L; Manson, JE; Martin, LW; Prentice, RL; Rossouw, JE; Trevisan, M | 1 |
2 other study(ies) available for 27-hydroxycholesterol and Coronary Heart Disease
Article | Year |
---|---|
An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol.
Topics: Adult; Biological Transport; Cholestanetriol 26-Monooxygenase; Cholesterol; Coronary Disease; Humans; Hydroxycholesterols; Lipoproteins, HDL; Male; Myocardial Infarction; Radiography; Xanthomatosis, Cerebrotendinous | 2010 |
Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.
Topics: Aged; Biomarkers; Case-Control Studies; Cholesterol, LDL; Coronary Disease; Estrogen Replacement Therapy; Female; Follow-Up Studies; Humans; Hydroxycholesterols; Menopause; Middle Aged; Receptors, Estrogen; Risk Factors; Treatment Outcome | 2012 |